BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35328794)

  • 1. Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer.
    Dakowicz D; Zajkowska M; Mroczko B
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
    Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
    World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VEGF signaling pathway in cancer: the road ahead.
    Stacker SA; Achen MG
    Chin J Cancer; 2013 Jun; 32(6):297-302. PubMed ID: 23419196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z; Hou Q; Guo H
    Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Endothelial Growth Factor Ligands and Receptors in Breast Cancer.
    Brogowska KK; Zajkowska M; Mroczko B
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma.
    Shintani S; Li C; Ishikawa T; Mihara M; Nakashiro K; Hamakawa H
    Oral Oncol; 2004 Jan; 40(1):13-20. PubMed ID: 14662410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0056618 promoted cell proliferation, migration and angiogenesis through sponging with miR-206 and upregulating CXCR4 and VEGF-A in colorectal cancer.
    Zheng X; Ma YF; Zhang XR; Li Y; Zhao HH; Han SG
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4190-4202. PubMed ID: 32373955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis and anti-angiogenic therapies.
    Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
    Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor signaling pathways: therapeutic perspective.
    Kowanetz M; Ferrara N
    Clin Cancer Res; 2006 Sep; 12(17):5018-22. PubMed ID: 16951216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
    Melincovici CS; Boşca AB; Şuşman S; Mărginean M; Mihu C; Istrate M; Moldovan IM; Roman AL; Mihu CM
    Rom J Morphol Embryol; 2018; 59(2):455-467. PubMed ID: 30173249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporamin suppresses growth of xenografted colorectal carcinoma in athymic BALB/c mice by inhibiting liver β-catenin and vascular endothelial growth factor expression.
    Yang C; Zhang JJ; Zhang XP; Xiao R; Li PG
    World J Gastroenterol; 2019 Jul; 25(25):3196-3206. PubMed ID: 31333311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis.
    Tjwa M; Luttun A; Autiero M; Carmeliet P
    Cell Tissue Res; 2003 Oct; 314(1):5-14. PubMed ID: 13680354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
    Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
    Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.
    Bender RJ; Mac Gabhann F
    BMC Syst Biol; 2015 Sep; 9():55. PubMed ID: 26341082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biology of vascular endothelial growth factors.
    Tammela T; Enholm B; Alitalo K; Paavonen K
    Cardiovasc Res; 2005 Feb; 65(3):550-63. PubMed ID: 15664381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
    Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
    J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.